Status:

COMPLETED

Preventing Recurrent Vascular Events in Patients With Stroke or Transient Ischemic Attack

Lead Sponsor:

University of Alberta

Collaborating Sponsors:

Heart and Stroke Foundation of Canada

Alberta Heritage Foundation for Medical Research

Conditions:

Ischemic Stroke

Transient Ischemic Attacks

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

People who have had a stroke or transient ischemic attack (TIA or "mini-stroke") are at high risk of having another stroke or a heart attack. Conditions like high blood pressure and high cholesterol, ...

Detailed Description

BACKGROUND: Epidemiological studies have shown that a number of conditions increase the risk of stroke and other vascular diseases and there is compelling evidence from large randomized trials that tr...

Eligibility Criteria

Inclusion

  • A stroke specialist-determined ischemic stroke or TIA within the past year (including ocular strokes/TIA such as amaurosis fugax).
  • Presence of systemic hypertension (average systolic blood pressure over two visits - i.e., SPC visit and study screening visit- exceeding 140 mmHg) OR fasting LDL cholesterol exceeding 2.0 mmol/L OR total: HDL cholesterol ratio exceeding 4.0 at SPC visit.

Exclusion

  • Neurological event considered to be due to intracranial hemorrhage (e.g., ICH, SAH), or trauma induced, or related to structural heart disease such as ASD/VSD or endocarditis.
  • Foreshortened life-expectancy (e.g., active malignancy), hypertensive crisis (clinic systolic BP \> 200 mm Hg), or severe comorbidities.
  • Institutionalized in a long-term care facility.
  • Cognitive impairment (defined as a score of \> 5 on the Short Portable Mental Status questionnaire).
  • Already on maximal therapy for risk factors (on 3 antihypertensive drugs at maximal dose if hypertension is inclusion criterion or on maximal dose statin if hyperlipidemia is inclusion criterion).

Key Trial Info

Start Date :

January 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2013

Estimated Enrollment :

279 Patients enrolled

Trial Details

Trial ID

NCT00931788

Start Date

January 1 2009

End Date

November 1 2013

Last Update

October 15 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Alberta Hospital

Edmonton, Alberta, Canada, T6G 2B7